Variant report

Variant	esv3433275
Chromosome Location	chr12:117796919-117800317
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr12:117798948-117799118	H1-hESC	embryonic stem cell:	n/a	n/a
2	CHD1	chr12:117799187-117799387	H1-hESC	embryonic stem cell:	n/a	n/a
3	CHD2	chr12:117798296-117798424	H1-hESC	embryonic stem cell:	n/a	chr12:117798389-117798399
4	CTBP2	chr12:117796790-117797594	H1-hESC	embryonic stem cell:	n/a	n/a
5	CTBP2	chr12:117798006-117799566	H1-hESC	embryonic stem cell:	n/a	n/a
6	GABPA	chr12:117798839-117799482	H1-hESC	embryonic stem cell:	n/a	chr12:117799296-117799305 chr12:117799294-117799303
7	GABPA	chr12:117798140-117798991	H1-hESC	embryonic stem cell:	n/a	n/a
8	GABPA	chr12:117798158-117798832	H1-hESC	embryonic stem cell:	n/a	n/a
9	JUND	chr12:117798712-117798902	H1-hESC	embryonic stem cell:	n/a	n/a
10	MAX	chr12:117798152-117798776	A549	lung:	n/a	n/a
11	POLR2A	chr12:117798428-117798435	H1-hESC	embryonic stem cell:	n/a	n/a
12	POLR2A	chr12:117798392-117798415	H1-hESC	embryonic stem cell:	n/a	n/a
13	POLR2A	chr12:117798474-117798707	H1-hESC	embryonic stem cell:	n/a	n/a
14	POLR2A	chr12:117799296-117799770	H1-neurons	neurons:	n/a	n/a
15	POLR2A	chr12:117798766-117799239	H1-hESC	embryonic stem cell:	n/a	n/a
16	POLR2A	chr12:117799250-117799618	H1-neurons	neurons:	n/a	n/a
17	POLR2A	chr12:117799302-117799363	H1-hESC	embryonic stem cell:	n/a	n/a
18	POLR2A	chr12:117798155-117799116	H1-neurons	neurons:	n/a	n/a
19	RAD21	chr12:117798738-117799482	H1-hESC	embryonic stem cell:	n/a	n/a
20	SIN3A	chr12:117798021-117799414	H1-hESC	embryonic stem cell:	n/a	chr12:117798476-117798487 chr12:117798484-117798497
21	TBP	chr12:117798855-117799053	H1-hESC	embryonic stem cell:	n/a	n/a
22	YY1	chr12:117798240-117798882	A549	lung:	n/a	chr12:117798621-117798635 chr12:117798369-117798383 chr12:117798476-117798487 chr12:117798511-117798521 chr12:117798666-117798676 chr12:117798871-117798882
23	YY1	chr12:117798186-117799020	H1-hESC	embryonic stem cell:	n/a	chr12:117798621-117798635 chr12:117798369-117798383 chr12:117798231-117798242 chr12:117798476-117798487 chr12:117798511-117798521 chr12:117798666-117798676 chr12:117798871-117798882
24	YY1	chr12:117798192-117799015	H1-hESC	embryonic stem cell:	n/a	chr12:117798621-117798635 chr12:117798369-117798383 chr12:117798231-117798242 chr12:117798476-117798487 chr12:117798511-117798521 chr12:117798666-117798676 chr12:117798871-117798882
25	ZNF143	chr12:117798904-117799364	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:117799447-117799497	RPTEC	kidney:	n/a
2	chr12:117798077-117798127	ovcar-3	ovarian:	n/a
3	chr12:117797116-117797166	HEEpiC	esophagus:	n/a
4	chr12:117799447-117799497	RPTEC	kidney:	n/a
5	chr12:117798077-117798127	ovcar-3	ovarian:	n/a
6	chr12:117797116-117797166	HEEpiC	esophagus:	n/a
7	chr12:117798627-117798677	IMR90	lung:	fetal
8	chr12:117797209-117797259	BE2_C	brain:	n/a
9	chr12:117798135-117798185	BE2_C	brain:	n/a
10	chr12:117798954-117799004	Jurkat	blood:	n/a
11	chr12:117797116-117797166	HCM	heart:	n/a
12	chr12:117798748-117798798	SK-N-MC	brain:	n/a
13	chr12:117799447-117799497	ProgFib	skin:	n/a
14	chr12:117798077-117798127	GM12891	blood:	n/a
15	chr12:117797635-117797685	MCF10A-Er-Src	breast:	n/a
16	chr12:117798748-117798798	CMK	blood:	n/a
17	chr12:117798954-117799004	PrEC	prostate:	n/a
18	chr12:117798748-117798798	HepG2	liver:	n/a
19	chr12:117797056-117797106	LNCaP	prostate:	n/a
20	chr12:117798748-117798798	ProgFib	skin:	n/a
21	chr12:117797385-117797435	AG10803	skin:	n/a
22	chr12:117798135-117798185	PFSK-1	brain:	n/a
23	chr12:117799083-117799133	ovcar-3	ovarian:	n/a
24	chr12:117800240-117800290	GM12891	blood:	n/a
25	chr12:117797116-117797166	HRPEpiC	eye:	n/a
26	chr12:117799370-117799420	HEK293	kidney:	embryo
27	chr12:117798954-117799004	NH-A	brain:	n/a
28	chr12:117798954-117799004	HepG2	liver:	n/a
29	chr12:117798954-117799004	PFSK-1	brain:	n/a
30	chr12:117798748-117798798	HAEpiC	amniotic membrane:	n/a
31	chr12:117798135-117798185	AG09309	skin:	n/a
32	chr12:117797385-117797435	HRCEpiC	kidney:	n/a
33	chr12:117800240-117800290	HIPEpiC	eye:	n/a
34	chr12:117797209-117797259	HCF	heart:	n/a
35	chr12:117799447-117799497	PANC-1	pancreas:	n/a
36	chr12:117798135-117798185	GM12878	blood:	n/a
37	chr12:117797635-117797685	ovcar-3	ovarian:	n/a
38	chr12:117800240-117800290	SK-N-MC	brain:	n/a
39	chr12:117798748-117798798	PrEC	prostate:	n/a
40	chr12:117798748-117798798	HEEpiC	esophagus:	n/a
41	chr12:117799370-117799420	CMK	blood:	n/a
42	chr12:117797385-117797435	HCF	heart:	n/a
43	chr12:117798077-117798127	HCT-116	colon:	n/a
44	chr12:117797209-117797259	PFSK-1	brain:	n/a
45	chr12:117798077-117798127	RPTEC	kidney:	n/a
46	chr12:117799370-117799420	HMEC	breast:	n/a
47	chr12:117799083-117799133	AG09309	skin:	n/a
48	chr12:117799447-117799497	Caco-2	colon:	n/a
49	chr12:117797116-117797166	HMEC	breast:	n/a
50	chr12:117799370-117799420	K562	blood:	n/a

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FBXW8-5	chr12:117797639-117797772	l_735_chr12:117793644-117842406_testes
2	lnc-KSR2-2	chr12:117799317-117799434	NONHSAT030992

Variant related genes	Relation type
NOS1	TF binding region
NOS1	CpG island

Extended variants
information (count: 133 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:133 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs557953504	chr12:117796938-117796939	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs190900833	chr12:117796952-117796953	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs71444623	chr12:117797000-117797001	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs374240767	chr12:117797003-117797004	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs3837440	chr12:117797006-117797007	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs182332611	chr12:117797011-117797012	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs374344873	chr12:117797020-117797021	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs553305926	chr12:117797030-117797031	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs573218123	chr12:117797076-117797077	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs368185075	chr12:117797089-117797090	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs555630934	chr12:117797116-117797117	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs112162485	chr12:117797175-117797176	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs75777658	chr12:117797183-117797184	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs397814754	chr12:117797189-117797190	Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs55784342	chr12:117797292-117797293	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs149472263	chr12:117797308-117797309	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs12425916	chr12:117797335-117797336	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs11613900	chr12:117797339-117797340	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs532946268	chr12:117797379-117797380	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs576841156	chr12:117797381-117797382	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs11609784	chr12:117797386-117797387	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs529589698	chr12:117797439-117797440	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs549816494	chr12:117797468-117797469	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs549242860	chr12:117797571-117797572	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs186564572	chr12:117797631-117797632	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs116762246	chr12:117797655-117797656	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
27	rs114735613	chr12:117797662-117797663	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
28	rs374799804	chr12:117797681-117797682	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
29	rs12322249	chr12:117797683-117797684	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
30	rs56787288	chr12:117797685-117797686	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
31	rs71099046	chr12:117797740-117797741	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
32	rs571601158	chr12:117797761-117797762	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
33	rs569701094	chr12:117797820-117797821	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs534293209	chr12:117797835-117797836	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs547860366	chr12:117797849-117797850	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs567645851	chr12:117797909-117797910	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs12828499	chr12:117797912-117797913	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs36021382	chr12:117797916-117797917	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs367841174	chr12:117797937-117797938	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs555667298	chr12:117797986-117797987	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs555831746	chr12:117798027-117798028	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs117506057	chr12:117798109-117798110	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs537597680	chr12:117798120-117798121	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs35276550	chr12:117798128-117798129	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs557845635	chr12:117798136-117798137	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs577703925	chr12:117798144-117798145	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs540318222	chr12:117798150-117798151	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs116522969	chr12:117798186-117798187	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs573284966	chr12:117798248-117798249	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs143951207	chr12:117798253-117798254	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	21390271	CNVD
Cancer	20164919	CNVD
Cancer	16751803	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Wilms tumour	21544195	CNVD
Ovarian cancer	21720365	CNVD
Colorectal cancer	16272173	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16397240	CNVD
Sudden cardiac death	19188705	CNVD
Breast cancer	17133270	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Schizophrenia	18923514	CNVD
Schizophrenia	22241247	CNVD
Cryptorchidism	21048976	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Neuroblastoma	18923191	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Neuroblastoma	20406844	CNVD
Medulloblastoma	16783165	CNVD
mental retardation	16760730	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21364760	CNVD
Lung adenocarcinoma	21045234	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21806811	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD

Chromatin state (count:150 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:117790000-117798000	Weak transcription	Psoas Muscle	Psoas
2	chr12:117796400-117800400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
3	chr12:117796600-117797000	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
4	chr12:117796600-117797200	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr12:117796600-117797200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
6	chr12:117796800-117797200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
7	chr12:117796800-117797400	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
8	chr12:117796800-117797400	Weak transcription	NHEK	skin
9	chr12:117796800-117797800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
10	chr12:117797000-117797200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
11	chr12:117797000-117799600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
12	chr12:117797000-117799600	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
13	chr12:117797200-117797400	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
14	chr12:117797200-117797400	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
15	chr12:117797200-117797400	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
16	chr12:117797200-117797400	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
17	chr12:117797200-117797400	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
18	chr12:117797200-117797400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
19	chr12:117797200-117797600	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr12:117797200-117797600	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
21	chr12:117797200-117798000	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
22	chr12:117797200-117798400	Bivalent/Poised TSS	Brain Germinal Matrix	brain
23	chr12:117797200-117799800	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
24	chr12:117797200-117800000	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
25	chr12:117797200-117801400	Bivalent Enhancer	Fetal Brain Male	brain
26	chr12:117797400-117797600	Flanking Bivalent TSS/Enh	H1 Derived Mesenchymal Stem Cells	ES cell derived
27	chr12:117797400-117797600	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
28	chr12:117797400-117797600	Bivalent Enhancer	Lung	lung
29	chr12:117797400-117797600	Enhancers	NHEK	skin
30	chr12:117797400-117797800	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
31	chr12:117797400-117797800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
32	chr12:117797400-117798600	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
33	chr12:117797400-117799600	Active TSS	Brain Anterior Caudate	brain
34	chr12:117797600-117797800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
35	chr12:117797600-117797800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
36	chr12:117797600-117797800	Weak transcription	NHEK	skin
37	chr12:117797600-117798000	Bivalent/Poised TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
38	chr12:117797600-117798000	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell
39	chr12:117797600-117799800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
40	chr12:117797800-117798000	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
41	chr12:117797800-117798000	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
42	chr12:117797800-117798200	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
43	chr12:117797800-117798200	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
44	chr12:117797800-117798200	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
45	chr12:117797800-117798400	Bivalent/Poised TSS	Fetal Intestine Small	intestine
46	chr12:117797800-117799000	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
47	chr12:117797800-117799200	Bivalent/Poised TSS	A549	lung
48	chr12:117797800-117799400	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
49	chr12:117797800-117799400	Active TSS	NHEK	skin
50	chr12:117797800-117799600	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links